Sherwin-Williams (NYSE:SHW) Price Target Raised to $370.00 at Barclays

Sherwin-Williams (NYSE:SHW) had its price objective hoisted by stock analysts at Barclays from $355.00 to $370.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective would indicate a potential upside of 2.33% from the stock’s current price.

Several other equities research analysts have also recently issued reports on SHW. StockNews.com upgraded Sherwin-Williams from a “hold” rating to a “buy” rating in a report on Tuesday. Jefferies Financial Group lifted their price target on Sherwin-Williams from $392.00 to $415.00 and gave the company a “buy” rating in a report on Monday, August 26th. Morgan Stanley increased their price objective on shares of Sherwin-Williams from $375.00 to $450.00 and gave the stock an “overweight” rating in a report on Friday, October 18th. UBS Group restated an “underperform” rating on shares of Sherwin-Williams in a report on Friday, October 18th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $418.00 price objective on shares of Sherwin-Williams in a research report on Friday, August 30th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $395.29.

Sherwin-Williams Trading Down 0.3 %

NYSE:SHW opened at $361.59 on Wednesday. Sherwin-Williams has a 52-week low of $232.06 and a 52-week high of $392.57. The company has a quick ratio of 0.50, a current ratio of 0.83 and a debt-to-equity ratio of 1.97. The stock has a fifty day simple moving average of $371.81 and a 200-day simple moving average of $334.64. The company has a market capitalization of $91.68 billion, a PE ratio of 38.55, a price-to-earnings-growth ratio of 2.87 and a beta of 1.17.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.56 by ($0.19). The business had revenue of $6.16 billion for the quarter, compared to analyst estimates of $6.20 billion. Sherwin-Williams had a return on equity of 74.45% and a net margin of 11.09%. The business’s revenue was up .7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.20 EPS. On average, equities research analysts expect that Sherwin-Williams will post 11.31 earnings per share for the current fiscal year.

Insider Activity at Sherwin-Williams

In other news, CFO Allen J. Mistysyn sold 14,520 shares of Sherwin-Williams stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $366.83, for a total value of $5,326,371.60. Following the completion of the transaction, the chief financial officer now owns 63,520 shares in the company, valued at approximately $23,301,041.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Sherwin-Williams

A number of hedge funds have recently added to or reduced their stakes in the business. Griffin Asset Management Inc. grew its position in shares of Sherwin-Williams by 0.3% during the 3rd quarter. Griffin Asset Management Inc. now owns 9,296 shares of the specialty chemicals company’s stock valued at $3,548,000 after buying an additional 26 shares during the last quarter. Capital Advisors Ltd. LLC grew its holdings in shares of Sherwin-Williams by 2.4% during the third quarter. Capital Advisors Ltd. LLC now owns 1,201 shares of the specialty chemicals company’s stock valued at $458,000 after purchasing an additional 28 shares during the last quarter. GHP Investment Advisors Inc. raised its position in shares of Sherwin-Williams by 47.5% during the 3rd quarter. GHP Investment Advisors Inc. now owns 87 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 28 shares during the period. Allworth Financial LP lifted its holdings in shares of Sherwin-Williams by 1.8% in the 3rd quarter. Allworth Financial LP now owns 1,560 shares of the specialty chemicals company’s stock worth $595,000 after purchasing an additional 28 shares during the last quarter. Finally, Conning Inc. grew its stake in Sherwin-Williams by 1.9% during the 2nd quarter. Conning Inc. now owns 1,606 shares of the specialty chemicals company’s stock worth $479,000 after buying an additional 30 shares during the last quarter. Institutional investors and hedge funds own 77.67% of the company’s stock.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.